Reduced Plasma Dopamine-β-Hydroxylase Activity Is Associated With the Severity of Bipolar Disorder: A Pilot Study
Dopamine-β-hydroxylase (DβH) is an enzyme converting dopamine to norepinephrine, a key neurotransmitter in mood disorders, such as major depressive disorder (MDD) and bipolar disorder (BD). Due to overlapping symptomology of unipolar and bipolar depression, the present study attempted to explorer if...
Main Authors: | Zuoli Sun, Qijing Bo, Zhen Mao, Feng Li, Fan He, Christine Pao, Wenbiao Li, Yi He, Xin Ma, Chuanyue Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.566091/full |
Similar Items
-
Prepulse inhibition in patients with bipolar disorder: a systematic review and meta-analysis
by: Zhen Mao, et al.
Published: (2019-09-01) -
The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital
by: Yue Sun, et al.
Published: (2020-09-01) -
Novel Mutations in the Tyrosine Hydroxylase Gene in the First Czech Patient with Tyrosine Hydroxylase Deficiency
by: K. Szentiványi, et al.
Published: (2012-01-01) -
Involvement of tryptophan hydroxylase 2 gene polymorphisms in susceptibility to tic disorder in Chinese Han population
by: Zheng Ping, et al.
Published: (2013-01-01) -
Mutations in the gene of lysyl hydroxylase of patients with Ehlers-Danlos syndrome type VI
by: Pousi, B. (Birgitta)
Published: (1999)